Extraction of Vital Signs using a Telehealth Application for Asthma - EViTA-AThe purpose of this grant is to evaluate mobile devices to extract vitals signs to monitor patients with Asthma

哮喘是一种影响生活质量、生产力和医疗保健使用的慢性疾病，可以 最终导致死亡。哮喘的代价很大程度上是由于无法控制的疾病和 相应地，随着其流行率和严重性的增加而增加。不幸的是，事件的发生和影响 尽管广泛采用了有效的普遍治疗，哮喘发作的情况并未得到改善 医疗保健提供者的指导方针，揭示了促进实施和 监测一大批哮喘患者。我们试图改进对存在的检测 和哮喘发作的严重程度，以便对患者进行适当的分流，以便立即接受治疗 治疗与在家继续观察的对比。远程医疗提供了更好的机会 管理，但这些视觉和口头评估往往是不完整的，没有生命体征 测量。我们的远程监控和基于视频的生命体征捕获方法提供了 改变游戏规则的替代方案，以解决哮喘发作的初始表现和 通过改善对慢性哮喘症状的管理来预防。这是一项创新 技术将：(一)扩大医生的覆盖面和患者的可及性；(二)改善 向高风险患者提供保健服务的效率；(Iii)限制接触传染性疾病 患者和提供者的疾病；以及(Iv)利用现成的常见(相对)商业 (COTS)技术而不是昂贵的精品设备。与众不同的特点 哮喘(炎症、气道高反应性和重塑)是一种独特的表现 以及一系列复杂的分子相互作用，也表现为 导致观察到的临床表型的行为。我们的下一步是增强远程 通过开发生物心理社会方法来改进提取的生命体征的医学监测 哮喘的表型。归根结底，这里的方法将增强从每个 数字接触点可在成本更高之前改进对急性健康状态的早期检测 需要干预，从而改善生活质量，并为较低的自发性硬化症患者提供 哮喘或其他呼吸道疾病是获得医疗保健的更可行的手段。

Asthma is a chronic disease that affects quality of life, productivity, and healthcare use, and can ultimately lead to death. The costs of asthma are largely due to uncontrolled disease and accordingly rise as its prevalence and severity increase. Unfortunately, the incidence and impact of asthma attacks have not improved despite widespread adoption of effective universal treatment guidelines by healthcare providers, revealing an unmet need to facilitate implementation and monitoring of large groups of asthma patients. We seek to improve the detection of the presence and severity of an asthma attack for proper triage of patients to receive immediate medical treatment versus continued observation at home. Telemedicine provides an opportunity for better management, but these visual and verbal evaluations are often incomplete without vital sign measurements. Our approach of remote monitoring with video-based vital sign capture offers a game-changing alternative to address asthma attacks upon their initial presentation and prevention through improved management of chronic asthma symptoms. This innovative technology will: (i) extend the reach for physicians and accessibility for patients; (ii) improve efficiency of healthcare delivery to the highest risk patients; (iii) limit exposure to infectious disease for both patient and provider; and (iv) utilize common (relatively) commercial off the shelf (COTS) technologies instead of expensive boutique equipment. The distinguishing characteristics of asthma (inflammation, airway hyperreactivity and remodeling) are the expression of a unique and complex set of molecular interactions that also manifest as symptoms and changes in behavior that result in observed clinical phenotypes. Our next steps are to enhance remote medical monitoring with extracted vital signs by developing a biopsychosocial approach to refine phenotypes of asthma. Ultimately, the approach here will enhance the data gathered from each digital touchpoint to improve early detection of acute health status before more costly interventions are needed, thereby improving quality of life, and providing lower SES patients with asthma or other respiratory illnesses a more viable means to obtaining access to healthcare.